Global Health Limited (MEDANTA) - Total Liabilities
Based on the latest financial reports, Global Health Limited (MEDANTA) has total liabilities worth Rs19.21 Billion INR (≈ $207.72 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Global Health Limited - Total Liabilities Trend (2018–2026)
This chart illustrates how Global Health Limited's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Global Health Limited's working capital to evaluate short-term liquidity relative to the company's equity base.
Global Health Limited Competitors by Total Liabilities
The table below lists competitors of Global Health Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Monday.Com Ltd
NASDAQ:MNDY
|
USA | $933.51 Million |
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
USA | $25.32 Million |
|
CleanSpark Inc
NASDAQ:CLSK
|
USA | $1.93 Billion |
|
Hanmi Pharm Co Ltd
KO:128940
|
Korea | ₩694.79 Billion |
|
ENAGAS A.A. ADR1/2/EO150
F:EG40
|
Germany | €4.46 Billion |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
USA | $1.09 Billion |
|
Bullish
NYSE:BLSH
|
USA | $620.85 Million |
|
CGN Power Co Ltd
F:94C
|
Germany | €329.44 Billion |
Liability Composition Analysis (2018–2026)
This chart breaks down Global Health Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Global Health Limited market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Global Health Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Global Health Limited (2018–2026)
The table below shows the annual total liabilities of Global Health Limited from 2018 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs19.21 Billion ≈ $207.72 Million |
+39.31% |
| 2025-03-31 | Rs13.79 Billion ≈ $149.10 Million |
-1.41% |
| 2024-03-31 | Rs13.98 Billion ≈ $151.24 Million |
-17.14% |
| 2023-03-31 | Rs16.88 Billion ≈ $182.52 Million |
+10.35% |
| 2022-03-31 | Rs15.30 Billion ≈ $165.41 Million |
+16.60% |
| 2021-03-31 | Rs13.12 Billion ≈ $141.86 Million |
-0.38% |
| 2020-03-31 | Rs13.17 Billion ≈ $142.40 Million |
+15.15% |
| 2019-03-31 | Rs11.44 Billion ≈ $123.67 Million |
+49.17% |
| 2018-03-31 | Rs7.67 Billion ≈ $82.91 Million |
-- |
About Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emerg… Read more